The effects of anti-inflammatory drugs on vascular exudation evoked by cold injury.
D000813:Anilides / Q000627:therapeutic use*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use; D002199:Capillary Permeability / Q000187:drug effects*; D002934:Cinnamates / Q000627:therapeutic use*; D003080:Cold Temperature; D004396:Coloring Agents / Q000378:metabolism; D005029:Ethylenediamines / Q000627:therapeutic use; D005122:Exudates and Transudates / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D005615:Freezing; D005627:Frostbite / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007610:Kallikreins / Q000037:antagonists & inhibitors; D007705:Kinins / Q000037:antagonists & inhibitors; D008297:Male; D011725:Pyridines / Q000627:therapeutic use; D011727:Pyridinolcarbamate / Q000627:therapeutic use; D051381:Rats; D012702:Serotonin Antagonists; D012867:Skin / Q000293:injuries
D000813:Anilides; D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D002934:Cinnamates; D004396:Coloring Agents; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D007705:Kinins; D011725:Pyridines; D012702:Serotonin Antagonists; D011727:Pyridinolcarbamate; D007610:Kallikreins; D007213:Indomethacin